Prospective observational Italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Marco MaltoniDino Amadori

Abstract

Palliative sedation (PS) has been defined as the use of sedative medications to relieve intolerable suffering from refractory symptoms by a reduction in patient consciousness. It is sometimes necessary in end-of-life care when patients present refractory symptoms. We investigated PS for refractory symptoms in different hospice casemixes in order to (1) assess clinical decision-making, (2) monitor the practice of PS, and (3) examine the impact of PS on survival. This observational longitudinal cohort study was conducted over a period of 9 months on 327 patients consecutively admitted to two 11-bed Italian hospices (A and B) with different casemixes in terms of median patient age (hospice A, 66 years vs. hospice B, 73 years; P = 0.005), mean duration of hospice stay (hospice A, 13.5 days vs. hospice B, 18.3 days; P = 0.005), and death rate (hospice A, 57.2% vs. hospice B, 89.9%; P < 0.0001). PS was monitored using the Richmond Agitation-Sedation Scale (RASS). Sedated patients constituted 22% of the total admissions and 31.9% of deceased patients, which did not prove to be significantly different in the two hospices after adjustment for casemix. Patient involvement in clinical decision-making about sedation was significantly highe...Continue Reading

References

Sep 4, 1999·Palliative Medicine·C PeruselliI J Higginson
Apr 20, 2001·Journal of Pain and Symptom Management·T MoritaS Chihara
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tatsuya MoritaYosuke Uchitomi
Nov 8, 2002·American Journal of Respiratory and Critical Care Medicine·Curtis N SesslerR K Elswick
Apr 19, 2003·Palliative Medicine·Lars Johan MaterstvedtUNKNOWN EAPC Ethics Task Force
May 7, 2003·The Lancet Oncology·Nigel Sykes, Andrew Thorns
Aug 9, 2003·Lancet·Agnes van der HeideUNKNOWN EURELD consortium
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraJ Lynn Palmer
Nov 1, 2005·Journal of Pain and Symptom Management·Tatsuya MoritaUNKNOWN Japan Pain, Palliative Medicine, Rehabilitation, and Psycho-Oncology Study Group
Feb 21, 2006·Journal of Pain and Symptom Management·Guido MiccinesiUNKNOWN EURELD Consortium
Feb 15, 2007·Journal of Palliative Medicine·Alexander de Graeff, Mervyn Dean
Mar 29, 2008·Journal of Palliative Medicine·Mark F Carr, Gina Jervey Mohr
Apr 22, 2008·The Cochrane Database of Systematic Reviews·P GoodP Ravenscroft
Dec 17, 2008·Harvard Review of Psychiatry·Zev Schuman-OlivierBruce H Price
Jun 23, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MaltoniD Amadori
Jun 30, 2009·Journal of Pain and Symptom Management·Silvia van DoorenCarin C D van der Rijt
Aug 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ChernyF Strasser
Oct 28, 2009·Palliative Medicine·Nathan I ChernyUNKNOWN Board of the European Association for Palliative Care
May 18, 2010·Journal of Pain and Symptom Management·Timothy W KirkUNKNOWN Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee
Sep 8, 2010·The New England Journal of Medicine·Jennifer S TemelThomas J Lynch

❮ Previous
Next ❯

Citations

Apr 20, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Philipp R KlosaStephanie Stiel
Jun 1, 2014·Journal of Pain and Symptom Management·Shirley H BushPeter G Lawlor
Oct 18, 2016·Journal of Pain and Symptom Management·Tatsuya MoritaSatoru Tsuneto
Mar 31, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Santiago Parra PalacioAlicia Krikorian
Dec 10, 2014·The American Journal of Hospice & Palliative Care·Jacob J StrandKeith M Swetz
Apr 17, 2015·The Cochrane Database of Systematic Reviews·Elaine M BellerGeoffrey Mitchell
Sep 28, 2018·CNS Drugs·Ferdinando GarettoMarco Maltoni
Jan 17, 2019·The Journal of Medicine and Philosophy·Domnita O BadarauBernice S Elger
Feb 19, 2019·European Journal of Cancer Care·Francesca IngravalloPiero Morino
May 15, 2013·Current Opinion in Oncology·Marco MaltoniOriana Nanni
Oct 23, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Miguel Angel Benítez-Rosario, Belén Ascanio-León
Jun 21, 2020·BMC Palliative Care·Vincent GamblinChloé Prod'Homme
Oct 31, 2015·Journal of Palliative Care·Rogier H P D van DeijckRaymond T C M Koopmans
Dec 19, 2015·Cancer Control : Journal of the Moffitt Cancer Center·Marco Maltoni, Elisabetta Setola
Sep 23, 2020·Journal of Pain and Symptom Management·Maria ArantzamendiCarlos Centeno
Mar 20, 2018·Journal of Pain and Symptom Management·Augusto CaraceniUNKNOWN Italian Society of Palliative Care Study Group on Palliative Sedation in Adult Cancer Patients

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
Hilde T H van der KallenAgnes van der Heide
Revue médicale suisse
Karine Moynier-Vantieghem, M Beauverd
Journal of Pain and Symptom Management
Sebastiano MercadanteHome Care Italy Group
Nature Clinical Practice. Oncology
Nathan I Cherny
© 2022 Meta ULC. All rights reserved